Source:http://linkedlifedata.com/resource/pubmed/id/10716510
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-4-7
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
325
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10716510-Anti-HIV Agents,
pubmed-meshheading:10716510-Centers for Disease Control and Prevention (U.S.),
pubmed-meshheading:10716510-Cost-Benefit Analysis,
pubmed-meshheading:10716510-Drug Costs,
pubmed-meshheading:10716510-HIV Infections,
pubmed-meshheading:10716510-Humans,
pubmed-meshheading:10716510-Sexual Partners,
pubmed-meshheading:10716510-United States
|
pubmed:year |
2000
|
pubmed:articleTitle |
Is post-exposure prophylaxis affordable?
|
pubmed:publicationType |
Letter,
Comment
|